Glendale Biomed Private Limited, a active private limited company, was established on 04 March 2016 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74120MH2016PTC273873. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.20 Cr and a paid-up capital of ₹2.20 Cr.
It upholds a compliant status. Its leadership includes Suraj Prakash Singh (Additional Director), Pramod Yadav (Director). Past directors included Sameer Charandas Asher, Mandakini Mungi Mukund, Mohnish Ashok Shukla. It holds ₹3.47 Cr open charges and ₹5.10 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 204-E, B-Wing, Sumit Samarth Arcade, Tatya Tope Nagar, Aarey Road, Goregaon (, West), Mumbai, Maharashtra, 400062.
U74120MH2016PTC273873
273873
04 March 2016
₹2.20 Cr
₹2.20 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Glendale Biomed Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suraj Prakash Singh | Additional Director | 20 Apr 2020 | Current |
| Pramod Yadav | Director | 15 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Feb 2017 | Past |
| Pramod Abcsdd | Director | 08 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 04 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 10 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glendale Biomed Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 51.19% increase. The company also saw a substantial improvement in profitability, with a 140.17% increase in profit. The company's net worth Soared by an impressive increase of 134.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Glendale Biomed had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹34,700,000.00
₹51,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Nov 2022 | Others | ₹9.20 M | Open |
| 20 Jun 2022 | Others | ₹6.50 M | Open |
| 28 Jul 2021 | Canara Bank | ₹1.90 Cr | Open |
| 31 Dec 2020 | Others | ₹3.50 M | Satisfied |
| 05 Jul 2019 | Others | ₹4.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Glendale Biomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glendale Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glendale Biomed's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Glendale Biomed Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Glendale Biomed Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
The activity A charge with Others amounted to Rs. 0.92 Cr with Charge ID 100644111 was registered on 02 Nov 2022. was completed.
The activity A charge with Others amounted to Rs. 0.65 Cr with Charge ID 100586261 was registered on 20 Jun 2022. was completed.
The activity A charge registered on 05 Jul 2019 via Charge ID 100276653 with Others was fully satisfied on 08 Oct 2021. was completed.
The activity A charge registered on 31 Dec 2020 via Charge ID 100439606 with Others was fully satisfied on 15 Sep 2021. was completed.
The CIN of Glendale Biomed Private Limited is U74120MH2016PTC273873.
Glendale Biomed Private Limited is headquartered at 204-E, B-Wing, Sumit Samarth Arcade, Tatya Tope Nagar, Aarey Road, Goregaon (, West), Mumbai, Maharashtra, 400062.
Glendale Biomed Private Limited was incorporated on 04 March 2016.
The current directors of Glendale Biomed Private Limited are
The primary industry of Glendale Biomed Private Limited is Trade.
Glendale Biomed Private Limited is unlisted.
The authorized capital of Glendale Biomed Private Limited is ₹2.20 Cr, and the paid-up capital is ₹2.20 Cr.
The compliance status of Glendale Biomed Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX